Caisson Biotech LLC Newsroom - Profile and News Archive
Caisson Biotech, LLC is a collaboration driven biotechnology company specializing in the development of heparosan polymers to improve therapeutic drug delivery and performance. Caisson's HEPtune(r) technology was invented by Chief Scientist and University of Oklahoma Professor Dr. Paul DeAngelis, a world renowned glycobiology and enzyme specialist.
Caisson Biotech is a subsidiary of Heparinex, LLC.
Engage with Caisson Biotech LLC
Learn more online at: https://caissonbiotech.com/